Landsberg Gary M, Wilson Andrea L
Doncaster Animal Clinic, Thornhill, Ontario, Canada.
J Am Anim Hosp Assoc. 2005 Jan-Feb;41(1):3-11. doi: 10.5326/0410003.
Twenty-five cats exhibiting at least four episodes of vertical urine marking per week were assessed. Following a medical workup, a 4-week clomipramine trial was instituted, using a mean dose of 0.54 mg/kg per os q 24 hours. No concurrent behavioral or environmental modifications were applied. There was a statistically significant (P<0.0001) decrease in urine spraying when the cats were on clomipramine, with 20 of 25 cats having a > or =75% reduction in spraying within 4 weeks. Side effects were mild. Twenty cats were followed for an additional 5 months. Fifteen cats required medication to control the spraying, often at a reduced dose.
对每周至少出现四次垂直尿液标记行为的25只猫进行了评估。在进行医学检查后,开展了为期4周的氯米帕明试验,口服给药,平均剂量为每千克0.54毫克,每24小时一次。未同时进行行为或环境方面的调整。当猫服用氯米帕明时,尿液喷洒行为有统计学意义的显著减少(P<0.0001),25只猫中有20只在4周内尿液喷洒减少了75%或更多。副作用较轻。对20只猫又进行了5个月的跟踪观察。15只猫需要用药来控制尿液喷洒行为,且用药剂量常常降低。